Caspase-3 regulates cell cycle in B cells: A consequence of substrate specificity

Nature Immunology

Volumn 4, Issue 10, 2003, Pages 1016-1022

  Woo, Minna ^a,b   Hakem, Razqallah ^c,d   Furlonger, Caren ^a,d   Hakem, Anne ^c,d   Duncan, Gordon S ^c,d   Sasaki, Takehiko ^c,d   Bouchard, Denis ^c,d   Lu, Liwei ^a,d,e   Wu, Gillian E ^a,d,e,f   Paige, Christopher J ^a,d   Mak, Tak W ^c,d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Advanced Medical Discovery Institute   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; MITOGENIC AGENT; PROTEIN P21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN LYMPHOCYTE;

EID: 0142092617     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni976     Document Type: Article

References (41)

1. Nicholson, D.W. & Thornberry, N.A. Caspases: killer proteases. Trends Biochem. Sci. 22, 299-306 (1997).
2. Green, D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102, 1-4 (2000).
3. Hengartner, M.O. The biochemistry of apoptosis. Nature 407, 770-776 (2000).
4. Woo, M., Hakem, R. & Mak, T.W. Executionary pathway for apoptosis: lessons from mutant mice. Cell Res. 10, 267-278 (2000).
5. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470 (2002).
6. Fischer, U., Janicke, R.U. & Schulze-Osthoff, K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10, 76-100 (2003).
7. Stroh, C. & Schulze-Osthoff, K. Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ. 5, 997-1000 (1998).
8. Widmann, C., Gibson, S. & Johnson, G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273, 7141-7147 (1998).
9. Ranger, A.M., Malynn, B.A. & Korsmeyer, S.J. Mouse models of cell death. Nat. Genet. 28, 113-118 (2001).
10. Vaux, D.L. & Korsmeyer, S.J. Cell death in development. Cell 96, 245-254 (1999).
11. Alam, A., Cohen, L.Y., Aouad, S. & Sekaly, R.P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190, 1879-1890 (1999).
12. Kennedy, N.J., Kataoka, T., Tschopp, J. & Budd, R.C. Caspase activation is required for T cell proliferation. J. Exp. Med. 190, 1891-1896 (1999).
13. Chau, B.N. et al. Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat. Cell. Biol. 4, 757-765 (2002).
14. Sherr, C.J. & Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
15. Gu, Y., Turck, C.W. & Morgan, D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710 (1993).
16. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
17. el-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
18. Waga, S., Hannon, G.J., Beach, D. & Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578 (1994).
19. Waseem, N.H., Labib, K., Nurse, P. & Lane, D.P. Isolation and analysis of the fission yeast gene encoding polymerase δ accessory protein PCNA. EMBO J. 11, 5111-5120 (1992).
20. Cip1. Genes Dev. 12, 3882-3888 (1998).
21. Zhang, H., Hannon, G.J. & Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758 (1994).
22. LaBaer, J. et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862 (1997).
23. Barboule, N., Baldin, V., Jozan, S., Vidal S. & Valette, A. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA. Int. J. Cancer 76, 891-896 (1998).
24. CIP1/WAF1 protein accumulation in head-and-neck cancer. Int. J. Cancer 74, 383-389 (1997).
25. cip1 protein in transitional cell bladder tumours and its prognostic value. Eur. Urol. 34, 237-243 (1998).
26. Li, K.K. et al. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma. Liver 22, 259-268 (2002).
27. Woo, M. et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12, 806-819 (1998).
28. Fulcher, D. & Wong, S. Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol. Cell Biol. 77, 559-564 (1999).
29. Cip1/Waf1 by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273, 19207-19212 (1998).
30. KIP1 involved in G1 growth arrest. Oncogene 18, 3324-3333 (1999).
31. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. & Leder, P.C. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 25, 675-684 (1995).
32. Balomenos, D. et al. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6, 171-176 (2000).
33. Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352 (1998).
34. Varfolomeev, E.E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
35. Salmena, L. et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17, 883-895 (2003).
36. Chun, H.J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395-399 (2002).
37. Park, J.A., Kim, K.W., Kim, S.I. & Lee, S.K. Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. Eur. J. Biochem. 257, 242-248 (1998).
38. Cayrol, C. & Ducommun, B. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene 17, 2437-2444 (1998).
39. Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557 (1995).
40. Kincade, P.W., Lee, G., Watanabe, S. & Scheid, M.P. Antigens displayed on murine B lymphocyte precursors. J. Immunol. 127, 2262-2268 (1981)
41. Ray, R.J. et al. Stromal cell independent maturation of IL-7 responsive pro-B cells. J. Immunol. 160, 5886-5897 (1998).